The combined use of sodium-glucose transport protein 2 (SGLT2) inhibitors and glucagon-like peptide-1 (GLP-1) receptor agonists may offer notable benefits for optimizing cardiovascular and renal outcomes...
LaVarne Burton Credit: American Kidney Fund New patient-focused guidelines from the American Kidney Fund (AKF) are helping individuals with chronic kidney disease (CKD) manage and treat...
Brendon Neuen, MBBS, PhD Credit: X.com Findings from a recent study are providing support for the combined use of sodium-glucose transport protein 2 (SGLT2) inhibitors and...
Chronic kidney disease (CKD) is a debilitating condition that affects the emotional, physical, and social well-being of affected patients, thereby reducing their quality of life (QoL)....
In a review article published in the journal Nature Reviews Cardiology, the authors provide a detailed overview of the global burden of heart failure, including the...
Tryptophan is a key amino acid in the human diet that is broken down by gut microorganisms, which convert it into multiple metabolites that have various...
Obesity is not just a matter of physical appearance; it is a complex health issue with far-reaching consequences. It is crucial to bring to attention the...
Kidneys play a critical role in overall health by removing waste products from the blood. When they fail to sufficiently filter out foreign elements, several serious,...
If there’s a diet promising good health, a longer life, and potential weight loss, why not learn more about it? The Mediterranean diet promises all that...
The use of semaglutide for non-diabetic obese patients with cardiovascular disease was first reported to be associated with significant benefit in the SELECT trial, where major...